Seelos Therapeutics, Inc. Shareholders' Equity
Seelos Therapeutics, Inc. had Shareholders' Equity of -$28.13 million as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-08-14
- 2024-06-30: Stockholders' Equity Attributable to Parent -$28.13M.
- 2024-03-31: Stockholders' Equity Attributable to Parent -$33.10M.
- 2023-12-31: Stockholders' Equity Attributable to Parent -$33.51M.
- 2023-09-30: Stockholders' Equity Attributable to Parent -$30.41M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2024-06-30 | -$28.13M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$33.10M 10-Q · filed 2024-08-14 | |
| 2023-12-31 | -$33.51M 10-Q · filed 2024-08-14 | |
| 2023-09-30 | -$30.41M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$47.18M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | -$20.66M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | -$10.61M 10-Q · filed 2024-08-14 | |
| 2022-09-30 | $7.88M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $26.23M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $45.64M 10-Q · filed 2023-08-11 | |
| 2021-12-31 | $57.32M 10-K · filed 2024-03-06 | |
| 2021-09-30 | $72.91M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $82.70M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $24.76M 10-Q · filed 2022-08-05 | |
| 2020-12-31 | $2.57M 10-K · filed 2023-03-10 | |
| 2020-09-30 | $6.69M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $3.71M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $6.76M 10-Q · filed 2021-08-06 | |
| 2019-12-31 | -$7.00K 10-K · filed 2022-03-04 | |
| 2019-09-30 | $10.35M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $4.94M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $3.04M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | -$4.71M 10-K · filed 2021-03-11 | $2.57M 10-K · filed 2019-03-28 |
| 2018-09-30 | -$3.49M 10-Q · filed 2019-11-07 | $4.11M 10-Q · filed 2018-10-31 |
| 2018-06-30 | -$2.39M 10-Q · filed 2019-11-07 | $5.28M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$1.92M 10-Q · filed 2019-08-01 | $4.29M 10-Q · filed 2018-05-03 |
| 2017-12-31 | -$1.26M 10-K · filed 2020-03-17 | $4.37M 10-K · filed 2018-03-01 |
| 2017-09-30 | $6.32M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $6.57M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $842.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$7.52M 10-K · filed 2019-03-28 | |
| 2016-09-30 | -$7.54M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | -$9.44M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$6.84M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$9.94M 10-K · filed 2018-03-01 | |
| 2015-09-30 | -$7.91M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$3.25M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $1.67M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.92M 10-K · filed 2017-03-13 | |
| 2014-09-30 | $12.00M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $11.85M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $8.89M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $10.97M 10-K · filed 2016-03-09 | |
| 2013-09-30 | $11.95M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $13.39M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$609.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $6.62M 10-K · filed 2016-03-09 | |
| 2012-09-30 | $23.54M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $16.84M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $20.17M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $4.82M 10-K · filed 2015-03-16 | $4.82M 10-K · filed 2012-03-13 |
| 2011-09-30 | $6.27M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $5.57M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $11.57M 10-K · filed 2014-03-17 | $11.57M 10-Q · filed 2011-08-15 |
| 2009-12-31 | $2.71M 10-K · filed 2013-03-18 | $2.71M 10-K · filed 2012-03-13 |
| 2008-12-31 | $1.53M 10-K · filed 2012-03-13 |